All the below links and tweets are in English.
取り急ぎ以下貼っておきます。
New Jersey Vol.9 (corporations: Johnson & Johnson)
today
Johnson & Johnson Covid-19 vaccine study paused due to unexplained illness in participant https://t.co/fFsmSQ7v9H
— CNBC (@CNBC) October 13, 2020
ツイッター検索で 上記製薬会社 及び Japan や 日本の5製薬会社各社名 を入れて出て来たもの
We're proud to share this powerful #NationalNursesWeek story. Learn how the 2011 earthquake & tsunami in Japan inspired the Tomodachi #JNJ Disaster Nursing Training Program, and meet the survivors-turned-nursing students rebuilding their communities: https://t.co/prdG4fDmBa pic.twitter.com/MQOgQDm8y8
— Johnson & Johnson (@JNJNews) May 8, 2019
In the aftermath of 2011’s Great East Japan Earthquake, #JNJ has partnered with @USJC to support reconstruction efforts. Learn how the program trains student #nurses to become frontline healthcare workers who help keep their communities safe: https://t.co/GkRRjKZ7vP #IDDR2018 pic.twitter.com/Jjs4D964Hk
— Johnson & Johnson (@JNJNews) October 15, 2018
#JNJ Chairman & CEO Alex Gorsky had breakfast w/industry leaders and Prime Minister Shinzo Abe of Japan to discuss #healthcare #innovation pic.twitter.com/AjwL4lminc
— Johnson & Johnson (@JNJNews) February 10, 2017
During a visit to Japan this week, Sandi Peterson spoke at the 12th annual Healthy Society Award Ceremony in Tokyo. pic.twitter.com/MtdXwN3JcR
— Johnson & Johnson (@JNJNews) April 1, 2016
ICYMI: #JNJ CEO Alex Gorsky spoke w/@WSJ about emerging innovation opportunities in Japan: http://t.co/DpQfhwBYJo pic.twitter.com/krG953vH6x
— Johnson & Johnson (@JNJNews) May 1, 2015
"I believe the most exciting new frontier in health care is wellness."-#JNJ CEO Alex Gorsky at U.S.-Japan seminar pic.twitter.com/HiRqjmOXEI
— Johnson & Johnson (@JNJNews) May 1, 2015
#JNJ CEO Alex Gorsky & Prime Minister @AbeShinzo discuss business & innovation at U.S.-Japan investment seminar. pic.twitter.com/b9J0IbPBiQ
— Johnson & Johnson (@JNJNews) May 1, 2015
#JNJ is the fastest growing top-10 global pharmaceutical company in the US, Europe and Japan – Duato
— Johnson & Johnson (@JNJNews) July 15, 2014
Congrats to the Japan-based awardees of the #WorldWithoutDisease Call4Proposal! We’re proud to work alongside today’s talented innovators to develop tmw’s game-changing healthcare solutions. Read more about these research projects here https://t.co/lO4pGWniPb pic.twitter.com/9LFY9Xa3Fr
— Johnson & Johnson Innovation (@JNJInnovation) August 28, 2020
We recognize that the daily operations of researchers and companies have been impacted by the ongoing COVID-19 pandemic. With that in mind, we have postponed the deadline for applications to the Japan-based #WorldWithoutDisease Call for Proposals to May 15 https://t.co/9GQf9pDJWo pic.twitter.com/GcUim2XxQn
— Johnson & Johnson Innovation (@JNJInnovation) April 9, 2020
Though we are seeking #innovation from within #Japan, our hope is that your early-stage #research will have the potential to reach millions of patients beyond Japan. Apply to the #WorldWithoutDisease Call for Proposals here https://t.co/4GSKAJYfSz pic.twitter.com/ECktNLknBj
— Johnson & Johnson Innovation (@JNJInnovation) March 30, 2020
With @JanssenGlobal, #TakedaPharmaceutical & #ShonanHealthInnovationPark, we launched the #WorldWithoutDisease Call for Proposals in Japan. Submit your science or technology by April 15, 2020! https://t.co/4GSKAJYfSz pic.twitter.com/eIJZPbN28k
— Johnson & Johnson Innovation (@JNJInnovation) March 30, 2020
Many congratulations to #championsofscience Dr. James Allison and Dr. Tasuku Honjo of Japan on receiving the 2018 #NobelPrize. https://t.co/T8NuUFUcp5
— Johnson & Johnson Innovation (@JNJInnovation) October 1, 2018
Today, we’re proud to announce a Memorandum of Understanding for research collaborations with @univkyoto, marking #JNJInnovation’s 3rd collaboration with academia in Japan @KyotoU_News @JanssenAP #JJIAP pic.twitter.com/3an6wy4Y4u
— Johnson & Johnson Innovation (@JNJInnovation) July 2, 2018
We look forward to building relationships with the academics, entrepreneurs and scientists at the University of Tokyo that can help accelerate ideas to better answer patients’ needs in Japan and beyond @UTokyo_News_en @JanssenAP @JanssenGlobal pic.twitter.com/61QF16mHfY
— Johnson & Johnson Innovation (@JNJInnovation) February 28, 2018
Today’s MoU ceremony with the University of Tokyo marks a long-lasting collaboration as part of our ongoing commitment to nurture the healthcare ecosystem & positively impact human health through innovation in Japan and around the world @UTokyo_News_en @JanssenAP @JanssenGlobal pic.twitter.com/wU7MO2Ag6g
— Johnson & Johnson Innovation (@JNJInnovation) February 28, 2018
We are in Tokyo, Japan with #JNJ’s Chief Scientific Officer Paul Stoffels and the University of Tokyo to announce a memorandum of understanding to work together in supporting Japan’s healthcare innovation ecosystem @UTokyo_News_en @JanssenAP @JanssenGlobal @JNJCares @JNJNews pic.twitter.com/uEhjDtruDw
— Johnson & Johnson Innovation (@JNJInnovation) February 28, 2018
Great crowd at the @BioJapanExpo as our Head of #APAC Innovation Center Dong Wu presents on #JJI's work w/ academia in Japan! pic.twitter.com/6nuiVZYMSN
— Johnson & Johnson Innovation (@JNJInnovation) October 12, 2017
Our own #JanssenBD Japan lead Rami Suzuki presents JJI's strategy for collaboration alongside valued partners @BioJapanExpo @JanssenAP pic.twitter.com/aiHSdyBIT9
— Johnson & Johnson Innovation (@JNJInnovation) October 12, 2017
Winner of Dr. Paul Janssen Award announced – Dr.Yoshinori Ohsumi of Japan! #BIO2016 pic.twitter.com/MlsOHIEGlB
— Johnson & Johnson Innovation (@JNJInnovation) June 8, 2016
Next week: Where is the coronavirus vaccine search at, and what will healthcare look like in the U.S. and Japan? Join a free webinar on 8/4 with experts William Hait of @JNJInnovation, Hardy Kagimoto of @HealiosJapan and Jeanette Takamura of @ColumbiaSSW.https://t.co/7Iab7gT7ce
— U.S.-Japan Council (@USJC) July 27, 2020
.@USAsiaPacific congratulates the participants of the 5th @USJC @TOMODACHI Johnson & Johnson Disaster Nursing Training Program from #Japan. Their hands-on training and new networks gives them the skills to face future medical challenges. pic.twitter.com/MGtJnbM7ng
— EAP Bureau (@USAsiaPacific) August 16, 2019
Jun Kusunoki, @JNJInnovation’s Director of New Ventures Japan, shares some perspective on how to bridge the gap between early-stage research and commercialization of #healthcare solutions at the Japan Healthcare Venture Summit @BioJapanExpo #ChampionsOfScience pic.twitter.com/Xr7W0mRu06
— Jenny (@jennyoan) October 11, 2018
https://twitter.com/JanssenAP/status/1177073498864279552
Do you know @JNJNews ranked 1st in the Nikkei Woman gender diversity ranking in Japan? Ai Hua and our D&I champions had a great discussion on ways to improve the working environment for women pic.twitter.com/1CLOelg79N
— Janssen Asia Pacific (@JanssenAP) August 2, 2018
Johnson & Johnson in talks with Japan for COVID-19 vaccine deals.https://t.co/xkLJXeMdwv
— Nikkei Asia (@NikkeiAsia) July 17, 2020
Japan's government in talks with Johnson & Johnson to secure COVID-19 vaccine https://t.co/2iaNwIAtNZ
— The Japan Times (@japantimes) July 17, 2020
#BREAKING: Johnson & Johnson is in talks with the government of Japan and the Bill and Melinda Gates Foundation about locking up allocations of its potential #COVID-19 vaccine.@JNJGlobalHealth@gatesfoundation@AbeShinzohttps://t.co/UhTEPMxsmB pic.twitter.com/Fni1EGDwYI
— Arab News Japan (@ArabNewsjp) July 16, 2020
New post: Johnson & Johnson in talks with Japan and the Gates Foundation about COVID-19 vaccine. https://t.co/h0hkrPUPct
— BiopharmaMASH (@bio_mash) July 20, 2020
Johnson & Johnson in COVID-19 vaccine deal with Gates Foundation, Japan: Johnson & Johnson… https://t.co/Xzx9ZGOEMR
— Samuel Odusami (@samuelodusami) July 16, 2020
#DRG epidemiology report estimates more than 2 million people living with #HIV across the United States, Western Europe and Japan. Detailed global report live now https://t.co/r92nrjx1mO @DRGinsights @JanssenAP @JNJNews https://t.co/Lw6etS8VQZ
— DRG Epidemiology (@DRG_Epi) August 17, 2018
Genmab Announces Approval of Darzalex® (daratumumab) in Frontline Multiple Myeloma in Japan https://t.co/q79WnxG7XT @Genmab @JNJNews @JanssenUS More Nordic life science business news at [LSS] at https://t.co/Y4sTWJwwTU pic.twitter.com/0mxJCMLbpY
— [iito] Life Science (@iitoLifeScience) August 22, 2019
WATCH: Johnson & Johnson offers $2 billion to buy Japan's Ci:z https://t.co/97P38qNx9W pic.twitter.com/rR07oOUCwW
— Reuters Business (@ReutersBiz) October 24, 2018
Johnson & Johnson offers $2 billion to buy Japan's Ci:z https://t.co/97P38qNx9W pic.twitter.com/Sw01MF7T48
— Reuters Business (@ReutersBiz) October 23, 2018
Johnson & Johnson makes $2.1 billion offer to buy out Japan cosmetics firm Ci:z https://t.co/JnlBg7uDcF
— Reuters Business (@ReutersBiz) October 23, 2018
Johnson & Johnson offers to buy remainder of Japan’s Ci:z https://t.co/6Uu3SsdH4t
— Financial Times (@FT) October 23, 2018
Johnson & Johnson offers to buy out Japan cosmetics firm Ci:z for $2.1-billion https://t.co/1HaDvBLHrK @GlobeBusiness pic.twitter.com/03HW7V1LKS
— The Globe and Mail (@globeandmail) October 23, 2018
U.S. giant Johnson & Johnson makes $2.1 billion offer to buy out Japan cosmetics firm Ci:z https://t.co/xSB6DakDPj
— The Japan Times (@japantimes) October 24, 2018
(Japan Times) U.S. giant #Johnson & #Johnson makes $2.1 billion offer to buy out #Japan cosmetics firm Ci:z : U.S. health care conglomerate Johnson & Johnson said on Tuesday it will buy all outstanding shares of Japanese skin .. https://t.co/TvWVEriwG0 pic.twitter.com/PppIwklzOS
— StoriesFlow.com (@storiesflowcom) October 24, 2018
An example of #global #brand value creation – as Johnson & Johnson offers to buy out Japan cosmetics firm Ci:z for $2.1-billion. https://t.co/2ziWnRAaQt
— Harvest Portfolios Group (@harvestetfs) October 24, 2018
.@JNJNews in talks with Japan, @gatesfoundation to lock in deals on #COVID19 #vaccine https://t.co/OBDo2FonBJ | #pharma #pharmanews #IndiaIncfightsCovid19
— ExpPharma (@ExpPharma) July 17, 2020
The Tomodachi J&J Disaster Nursing Training Program video by @JNJNews is a #SharecareAwards finalist. Created after the Great East Japan Earthquake & Tsunami, the program provides local nursing students leadership skills & disaster relief training: https://t.co/7wDnNQ7e9x pic.twitter.com/RULsOhIeHU
— Sharecare (@SharecareInc) March 6, 2019
Performance of top-20 pharma companies in 2018 https://t.co/sNusoivrtG @abbvie @Bayer @bmsnews @Celgene #Europe #Japan @JNJNews #pharma @Roche @TakedaPharma #USA
— The Pharma Letter (@ThePharmaLetter) August 27, 2019
New Darzalex approval in Japan https://t.co/bsw32vnzMS @Genmab @JanssenGlobal @JNJNews #biotech
— The Pharma Letter (@ThePharmaLetter) August 22, 2019
Up to six new HBV drugs set to launch by 2027 https://t.co/x5prE6B3EY #antivirals #china #europe @GileadSciences @ionispharma #Japan @JNJNews #pharma #research #USA
— The Pharma Letter (@ThePharmaLetter) May 30, 2019
Discuss #biocompatibility evaluation of #meddevs for #global registrations – #Europe #US #Japan #China @JNJNews https://t.co/Gb4khetgCX
— MedTech (@MedTechIC) October 31, 2016
…@jindo as part of a panel discussion with @JNJNews @alantennenberg @merckgroup @MENTOR_Hq and GHIT from Japan on communication challenges in global health chaired by @AJack of @ft_health https://t.co/kyCpWn8psb
— ISNTD (@ISNTD_Press) May 16, 2018
Our last panel discussion is all about increasing the number of women in #leadership positions with speakers such as Mayor of Providencia, Chile, Mayor of Yokohama, Japan, @JNJNews and women's entrepreneurs network! #APECChile2019 pic.twitter.com/IiWTW0PWja
— APEC Secretariat (@APEC) October 3, 2019
With every photo, #JNJ will donate $1 to moms and children in #VietNam. If you live in the US, Canada, the UK, and Japan or have any friends or relatives there, please share this information with them: https://t.co/vjnvj89WSi @donateaphoto @JNJCares @JNJNews #EveryPhotoMatters pic.twitter.com/GvenuowIrO
— UNICEF Viet Nam (@UNICEF_vietnam) December 6, 2018
Johnson & Johnson set to take full control of Japan's Ci:z. Read the News story on the OTCToolbox website. https://t.co/Zq8QHRE6hd @JNJNews
— OTCToolbox (@OTCToolbox) October 24, 2018
#ConferenceSeries #SurgicalNursing2018 #Osaka #Japan #August_08_09_2018 #Surgery #Nursing #Conferences Must attend #Event For more details PS: https://t.co/gPErZdaGfy @ASPS_News @IPSOSurgeons @UMichSurgery @MDT_Diabetes @iss_sic @JNJNews pic.twitter.com/IdDZG3IHvm
— Surgical Nursing (@NursingSurgical) April 13, 2018
@VerbSurgical @ethicon @JNJInnovation ONE Team great week in Korea and Japan discussing the future of surgery with leading surgeons. #roboticsurgery #digitalsurgery pic.twitter.com/gVXAaLqueI
— Verb Surgical (@VerbSurgical) December 8, 2017
Last session of #MDEpiNet Day 1 — robust panel on #CRNs for complex, cross-disciplinary devices ft. @JNJNews, @Medtronic, @US_FDA, academics and leaders from MDEpiNet-Japan chapter @hiro_stat @ksase pic.twitter.com/0X2zd26SUN
— MDEpiNet (@MDEpiNet_ppp) October 22, 2019
Fantastic variety of speakers here @SciFest4STEM in @CITScience4Life @Astro_Tani on Skype from Japan – Aine @Qualcomm and Gillian @JNJNews #STEMcareers #dowhatyoulove pic.twitter.com/UzCpbWQI2f
— SmartFutures (@SmartFuturesIE) April 20, 2018
Listening to inspiring keynote from Reiko Yajima, Ph.D. From SPARK Program @Stanford Translational Research School of Medicine #Kyoto #HVC 2019 #Japan @KyotoU_News @JLABS @JNJInnovation @AstellasUS @TakedaOncology @DNABARCODE @curaseninc pic.twitter.com/knKNuPfNAa
— Gitte Pedersen (@DNABARCODE) July 1, 2019
Even more great business connections at the #W20 #W20Japan with the @WEConnection Japan team and members and champions @JNJNews @JNJCares Japan together to support #WomensEmpowerment and #BuyWomenOwned pic.twitter.com/gqoSSJsvE1
— Elizabeth Vazquez (@CEOVazquez) March 26, 2019
Loved the #BusinessConnections made at the #W20 #W20Japan @WAW_Japan High-Level Panel on #WomenEntrepreneurs with great questions and support from @kagider @MEmpresarias @VdU_eV @ReemAlfrayan @apcoworldwide @Accenture @intel @MoodysCorp @JNJNews and @WEConnection Japan team pic.twitter.com/MnzxYCeDLy
— Elizabeth Vazquez (@CEOVazquez) March 24, 2019
Thanks to @intel @Accenture and @JNJNews for a successful @WEConnection launch event in #Japan! Thrilled to continue our collective work in advancing #SDG5 to empower #womenentrepreneurs around the globe! #WomenInBiz #SupplierDiversity #Tokoyo pic.twitter.com/jX4pBmHEFQ
— WEConnect Intl (@WEConnection) July 27, 2018
Today's news: #Trump optimistic for end to #tradewar with #China, US makes verbal #tradedeal with #Japan, @JNJNews hit with $572M fine for #OpioidEpidemic, #immigrationpolicy lawsuit, and Weinstein pleads not guilty to to charges | @kentcovington https://t.co/8qakIh9EjB pic.twitter.com/9IekWJ94kk
— WORLD Radio (@TWERadio) August 27, 2019
Since 2013, 2/3 of OECD countries introduced new policies on pay equality while Australia, UK, Japan, Germany & Sweden require some employers publish calcs showing gender pay gap annually. Hear about @JanssenANZ @JNJNews commitment 2gender equality & an inclusive & equal culture https://t.co/lpfslZbcKm
— Kathy Connell (@connell_kathy) March 15, 2018
Takeda @TakedaPharma agreed to sell its TachoSil surgical patch to privately held @CorzaHealth for €350 million.
This comes after the proposed deal between @TakedaPharma and @JNJNews did not go through owing to competition concerns by EU Commission.#Hemostats #BioSurgery https://t.co/jl6Udkk4PB
— Hemostats Expert (@HemostatsExpert) September 29, 2020
Top pharma execs discuss and share #bestpractices of what they're doing to meet the challenges of COVID-19 @LillyPad @JNJNews @Roche @Sanofi @Takeda @IFPMA https://t.co/HngTgXpJtH
— Ogilvy Cambridge (@OgilvyCambridge) March 20, 2020
Johnson & Johnson suspends plans of buying Takeda Pharmaceutical’s TachoSil. #JohnsonandJohnson #TachoSil #TakedaPharmaceutical #Ethicon #StockMarketNews #Coronavirus #FTC #EUregulators@JNJNews @JoeSimonsFTChttps://t.co/ntJHplfl5J
— iNVEZZ (@InvezzPortal) April 11, 2020
Takeda Pays Turnstone $120M to Start Alliance on Viral Cancer Therapies https://t.co/6kS2ZzTEmp via @Xconomy @angelMD_Inc @tjarthur @CurtanaPharma @MDAndersonNews @DanaFarber @NCIResearchCtr @AmericanCancer @GlobalCancerTec @JNJGlobalHealth @JNJInnovation @TakedaOncology
— Joseph N Macaluso MD FACS (@MacalusoJoseph) December 24, 2019
Johnson & Johnson abandons deal for Takeda's TachoSil surgical patch https://t.co/U2lfUXtMXb pic.twitter.com/btbXD34kv3
— Reuters (@Reuters) April 10, 2020
Johnson & Johnson, Takeda and Evotec join The Dementia Consortium https://t.co/Hq5pLMyeht
— Oxford Science Park (@OxfordSciencePK) February 14, 2019
Takeda, Johnson & Johnson and more join Clara Health's Boston-based patient empowerment push https://t.co/h1dxLonXeK pic.twitter.com/qKePShTLoP
— FiercePharma (@FiercePharma) September 6, 2017
BiomX received $24 million financing from OrbiMed, Johnson & Johnson and Takeda – https://t.co/5s3Aq06DU0 pic.twitter.com/m8Bb96HlJz
— GMPnews.Net (@GMPnewsNet) May 15, 2017
Biotech innovation being accelerated by Israeli incubator FutuRx https://t.co/igdMCeNuh1 funded by #JJDC, Takeda, Orbimed @JNJInnovation pic.twitter.com/24TG9qGoju
— Marian T. Nakada (@MNakada) December 5, 2016
J&J, #Takeda team up to open #Israeli #biotech incubator http://t.co/3gSehrkyl5 .@JNJNews pic.twitter.com/GJM2IYgUi8
— AFHU (@AmFriendsHU) January 19, 2015
"What is next for the Russian market?" with CEOs from TEVA, @pfizer, Takeda, @drreddysnews & @JNJNews #RPF2014 pic.twitter.com/usWGWRaJ6K
— Russian Pharma (@PharmaASI) June 17, 2014
#Peptide_Based_Cancer_Therapeutics Market Size Worth $17.18 Billion By 2027
Read More : https://t.co/k5GadYh4D3
major market participants :@AstraZeneca @Allergan @Pfizer @Takeda @Amgen,@JNJNews#peptidetherapeutics #healthcare pic.twitter.com/8LF46fwnPm
— karishma mulani (@karishmamulani5) July 28, 2020
https://twitter.com/ResearchNews_24/status/1093484353416556544
AbbVie, Astellas, Eli Lilly, Johnson & Johnson, Merck, Takeda, Boehringer, Microsoft, Sanofi, Novo Nordisk, @broadinstitute, @BCBSMA are included on Working Mother magazine's "Best 100 Companies" 2019 list https://t.co/gCg9Q0xutk
— Pearl Freier (@PearlF) September 24, 2019
How do @JNJNews, Takeda, @novonordisk, top 10 differ from 21-30 in Productive Innovation?https://t.co/5I958cdYg1 pic.twitter.com/ifAeo0tgWe
— Mike Rea, IDEA Pharma (@ideapharma) March 8, 2016
@JNJNews tops pharma’s Productive Innovation Index. Gains made by @takedapharma, @abbvie, Otsuka, @novonordiskhttps://t.co/5I958cvz7z
— Mike Rea, IDEA Pharma (@ideapharma) March 2, 2016
Bayer files prostate cancer drug darolutamide in Japan: Bayer has filed its prostate cancer drug darolutamide with Japanese regulators, in an attempt to ratchet up the pressure on rivals Johnson & Johnson and Pfizer/Astellas. https://t.co/2lCBqd2A6q
— cafepharma (@cafepharma) March 5, 2019
New 'peptoids' show promise in resistant prostate cancer: A new generation of anti-androgen drugs such as Pfizer and Astellas’ Xtandi and Johnson & Johnson’s Zytiga have increased survival rates in metastatic castration-resistant prostate cancer (mCRPC).… https://t.co/FWKhBlnrCm
— cafepharma (@cafepharma) October 27, 2018
Bayer's Nubeqa scores key prostate cancer win in battle with Pfizer, J&J. Can this latest data help Nubeqa overcome it’s being third to market behind Pfizer and Astellas’ Xtandi and Johnson & Johnson’s Erleada? https://t.co/oCZsUjv3hh $PFE $JNJ $ALPMY $BAYN pic.twitter.com/q37wpJgj3U
— Bionest Partners (@BionestPartners) January 31, 2020
CANCER THERAPEUTICS Market: Types, Causes and Treatments | AbbVie, Inc., Johnson & Johnson, Celgene Corporation, Astellas Pharma, Inc. – Health News Office | @scoopit https://t.co/gqFeduAc4B
— Report Ocean (@ReportOcean) October 24, 2019
Cancer Treatment Drugs Market Size, Growth, Share and Top Players to 2026: Amgen, Roche, Novartis, Johnson & Johnson, Pfizer, Eli Lilly, Astellas https://t.co/9tASuYljgR pic.twitter.com/CxDF4MHAOF
— PressRelease.cc (@PressRelease_cc) October 1, 2019
.@Bayer has filed its prostate cancer drug #darolutamide with Japanese regulators, in an attempt to ratchet up the pressure on rivals Johnson & Johnson and Pfizer/Astellas https://t.co/bQctr3VxMs #pharmanews #oncology pic.twitter.com/GLUlkJqTEQ
— pharmaphorum (@pharmaphorum) March 8, 2019
Bayer has filed its prostate cancer drug darolutamide with Japanese regulators, in an attempt to ratchet up the pressure on rivals Johnson & Johnson and Pfizer/Astellas…. https://t.co/woWqLujfOV
— Pharma, Device Recruiting Asia (@MorundaGroup) March 6, 2019
Fibromyalgia Treatments Market 2019 – Major Participants: GlaxoSmithKline, Astellas Pharma, Johnson & Johnson, ALLERGAN, Sunovion Pharms, Jazz Pharmaceuticals, ABBOTT Etc – openPR #fms https://t.co/zq29d5nSue
— FMS News bot (@fmsbot) February 6, 2019
Pfizer, Astellas speed up 2 Xtandi studies in market duel with Johnson & Johnson. Will the acceleration of these trials help $PFE and Astellas in their competition with $JNJ in prostate cancer? #pcsm https://t.co/mejJGeIBBF pic.twitter.com/4Eoop5ngXb
— Bionest Partners (@BionestPartners) August 24, 2018
#Prostatecancer shake-up looms with new data from Pfizer, Astellas and Johnson & Johnson | FiercePharma https://t.co/jd4boefjnc by @FiercePharma pic.twitter.com/7x7em8AObz
— Advera Health (@AdveraHealth) February 19, 2018
Prostate cancer shake-up looms with new data from Pfizer, Astellas and Johnson & Johnson https://t.co/AaTJi402QB pic.twitter.com/0zZ7BTBpmL
— Pharmamarketeer (@Pharmamarketeer) February 9, 2018
Prostate cancer shake-up looms with new data from Pfizer, Astellas and Johnson & Johnson https://t.co/Omo8TfcJqm pic.twitter.com/0gM0pFY8fC
— RxDataScience Inc. (@RxDataScience) February 6, 2018
Global Castration Resistant Prostate Cancer Treatment Market 2017-2021 with Astellas Pharma, Johnson & Johnson,… https://t.co/CIpB5p1J75 pic.twitter.com/ExCDuuKlt7
— Business Wire-Health (@BW_Health) July 21, 2017
Ten big pharma – @Astrazenenca, @Gsk, @JNJNews, @Amgen, @Astellas, @Bayer, @Boehringer, @Merck, @Novartis, @Servier – join forces to use #AI for #drugdiscovery https://t.co/MDTfBQ5OTx #digitalHealth #blockchain #machinlearning #HealthcareIT
— PHARMAMEDIX (@PHARMAMEDIX) June 7, 2019
@JNJNews has the most bucks for #biopharma M&A, #Astellas the easiest target: analyst #biotech #biotechnology #pharma #healthcare #mergersandacquisitions #MandA $JNJ $GILD $PFE $AZN $NVS $MRK $BMY $AGN $RHHBY https://t.co/RtHZyoUJjq
— Kara Jill Stancell (@kjilly) May 29, 2018
As a major conference on tuberculosis nears, Doctors Without Borders is pressuring suppliers of key medicines — Johnson & Johnson, Mylan and Otsuka Pharmaceuticals — to lower their prices by significant amounts. https://t.co/oPYbMbRY2p
— STAT (@statnews) October 11, 2019
Schizophrenia Market Growth, Updated Business Strategies and Opportunities|Johnson & Johnson Services, AstraZeneca, Bristol-Myers Squibb Company/Otsuka Holdings Co. Ltd.https://t.co/BfOskoL0Od#news #pharma #pharmiweb
— Pharma News (@pharminews) July 31, 2020
Trending: Central Nervous System Therapeutic Market Size, Key Trends, Challenges and Standardization, Research, Key Players, Economic Impact and Forecast to 2026| Biogen, Pfizer, Teva, Novartis, Johnson & Johnson, EliLilly, Otsuka – 3rd … – https://t.co/um63Ln75cY
— General Physics Lab (@genphys) July 15, 2020
#tuberculosis Drugs Market: Competitive Intelligence and Tracking Report 2018-2026 | Major Players @JNJCares Johnson & Johnson Services, Lupin Ltd, @Novartis AG, Macleods Pharmaceuticals, Otsuka Pharmaceutical Co, @pfizer https://t.co/NELVSxfy25 pic.twitter.com/xc2TrxQthw
— Michael Jaikishan (@Michaeljaikish1) October 16, 2019
@PA_Consulting are with us this morning and they brought @AstraZeneca @JNJInnovation & Otsuka to meet with our @GotoGrow_London companies pic.twitter.com/IwUXNxV9Fu
— Alban REMY (@Alban_remy) June 27, 2017
Invokana (Canagliflozin; Johnson & Johnson/Mitsubishi Tanabe/Daiichi Sankyo) Drug Overview & Outlook 2016-2018 to 2025 – https://t.co/guyiBzPH8C https://t.co/GfBqliZcnY pic.twitter.com/xvb1KAUuda
— Latest News from Business Wire (@NewsFromBW) May 11, 2018
Invokana (canagliflozin; Johnson & Johnson/Mitsubishi Tanabe/Daiichi Sankyo) Drug Analysis 2018 – https://t.co/guyiBzPH8C https://t.co/utjYIBlmwL pic.twitter.com/UkJhLWVdgr
— Latest News from Business Wire (@NewsFromBW) March 29, 2018
Vitamin K Antagonists (VKA) Market 2025: Size, Share, Driving Factors, Revenue and Trends 2020| Sanofi, Daiichi Sankyo, Johnson & Johnson, Bristol-Myers Squibb, Lilly, Bayer – The Market Chronicles, https://t.co/0Ut1D4opSu #tech
— covidnews.ch (@covidnewsCH) September 10, 2020
https://twitter.com/HAccordingly/status/1221321860236955649
Global Stroke Treatment Market Report 2019-2027 Featuring Bristol-Myers Squibb, Boehringer Ingelheim, Daiichi Sankyo, Roche, Johnson & Johnson Services, Sanofi, Amgen, Biogen, and AstraZeneca https://t.co/5q9QUZCO2F
— NEWS FOR FOREX (@NEWSFORFOREX1) January 24, 2020
Global Anti-Hypertensive Drugs Markets 2015-2019 & Forecast to 2030 – Merck, Astra Zeneca, Daiichi Sankyo, Johnson & Johnson and Pfizer are the Major Players – https://t.co/8vPVgQlQhj https://t.co/9eCVTB5X9r
— Pharmacutical Daily (@PharmacDaily) November 7, 2019
US Anticoagulation Therapy Market |C. H. Boehringer Sohn (Germany), Bristol-Myers Squibb (US), Johnson & Johnson (US), Pfizer (US), Daiichi Sankyo (Japan), and Portola Pharmaceuticals (US) are the major market players https://t.co/s5ySyvfOIN pic.twitter.com/BcFaVkyaeo
— gajanan_s (@gajanans7) March 6, 2019
Alzheimer’s Disease Drug Market Trends, Analysis by Regions, Type, Application, Market Drivers, Restraints, and Top Key Players like Allergan, Eisai, Novartis, Daiichi Sankyo, Johnson & Johnson and Forecast to 2023 https://t.co/LipGE2ZEQc via @IndustryToday
— Industry Today (@IndustryToday) January 28, 2019
US Anticoagulation Therapy Market to 2022 – Major Players are C. H. Boehringer Sohn, Bristol-Myers Squibb, Johnson & Johnson, Pfizer, Daiichi Sankyo and Portola Pharmaceuticals https://t.co/0CWnNmUvzZ
— Seattle's Banker (@SeattlesBanker) November 17, 2017
#NTD supply chain at #Merck attended by #Eisai, @pfizer @GSK #MSD @JNJNews @DeutschePostDHL on #schistosomiasis pic.twitter.com/ViNezXdIKC
— Merck (@merckgroup) June 28, 2016
The #pharma companies involved are: @GSK, Eisai, @JnJnews, @Merck & Co., Merck KGaA, @pfizer.
— Access to Medicine Foundation (@AtMIndex) November 17, 2014
#WIPOReSearch Member companies Eisai, GSK, Johnson & Johnson, and Takeda featured in November Partnership Hub Snapshot. Advancing drug discovery around #NTDs, #malaria, and #tuberculosis. https://t.co/rtLTaYv0uA@Eisai_SDGs, @GSK, @JNJGlobalHealth, @TakedaPharma, @WIPO pic.twitter.com/mnm0AJo3Ai
— BVGH (@BIOVentures) November 12, 2019
Really glad to support the World Metastasis Summit and join AstraZeneca, The Janssen Pharmaceutical Companies of Johnson & Johnson, Eisai US…#oncology #metastasis #drugdiscovery #inovotion #preclinical #medicalsciences #research https://t.co/8wKH9ozRer
— Philippe Fornies (@ForniesPhilippe) September 18, 2019
Global Lennox-Gastaut Syndrome Treatment Market 2019-2023 – Key Players are Eisai, GlaxoSmithKline, H. Lundbeck, Johnson & Johnson Services, and Supernus Pharmaceuticals – https://t.co/SdubibH8Fr – Associated Press https://t.co/xSlG3H7own
— IDRO (@IDROOhio) April 22, 2019
Global Lennox-Gastaut Syndrome Treatment Market 2019-2023 – Key Players are Eisai, GlaxoSmithKline, H. Lundbeck, Johnson & Johnson Services, and Supernus Pharmaceuticals – https://t.co/guyiBzPH8C https://t.co/WFXbokdAZH pic.twitter.com/KRmMxi9gLs
— Latest News from Business Wire (@NewsFromBW) April 22, 2019
Major pharmaceutical companies including Eisai, GlaxoSmithKline, Johnson & Johnson, Merck, and Pfizer have given billions of dollars’ worth of pharmaceutical products, as well as cash, to help eliminate global diseases. https://t.co/xv4DFMIcbN
— The Chronicle of Philanthropy (@Philanthropy) October 1, 2018
Well done BD, bioMérieux, Boehringer Ingelheim, Bristol-Myers Squibb, Eisai, Eli Lilly, Gilead, GSK, Johnson & Johnson, Merck (known as MSD outside the U.S. and Canada), Merck KGaA, Novartis, Pfizer, and Sanofi. https://t.co/f4ATL9azds
— Adam P Roberts (@GCAGATGCAATG) March 26, 2020
